239 related articles for article (PubMed ID: 35116546)
1. Bioinformatic analysis of the expression and prognosis of ZNF589 in human breast cancer.
Fan J; Zhang Z; Chen D; Chen H; Yuan W; Zhou L; Xu J; Liu W; Xu Y
Transl Cancer Res; 2021 May; 10(5):2286-2304. PubMed ID: 35116546
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
Sun M; Tang C; Liu J; Jiang W; Yu H; Dong F; Huang C; Rixiati Y
BMC Cancer; 2021 Jun; 21(1):696. PubMed ID: 34120621
[TBL] [Abstract][Full Text] [Related]
3. CLIP4 Shows Putative Tumor Suppressor Characteristics in Breast Cancer: An Integrated Analysis.
Fan Y; He L; Wang Y; Fu S; Han Y; Fan J; Wen Q
Front Mol Biosci; 2020; 7():616190. PubMed ID: 33575272
[No Abstract] [Full Text] [Related]
4. Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification.
Liu Z; Liu J; Liu R; Xue M; Zhang W; Zhao X; Zhu J; Xia P
BMC Cancer; 2021 Apr; 21(1):367. PubMed ID: 33827486
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancer.
Ye M; Li L; Liu D; Wang Q; Zhang Y; Zhang J
PeerJ; 2021; 9():e12276. PubMed ID: 34721975
[TBL] [Abstract][Full Text] [Related]
6. Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy.
Liang Z; Wang X; Dong K; Li X; Qin C; Zhou H
Biomed Res Int; 2021; 2021():5575704. PubMed ID: 33977106
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of HMGB3 and its prognostic value in breast cancer.
Zhou X; Zhang Q; Liang G; Liang X; Luo B
Front Oncol; 2022; 12():1048921. PubMed ID: 36620553
[TBL] [Abstract][Full Text] [Related]
8. The stem cell zinc finger 1 (SZF1)/ZNF589 protein has a human-specific evolutionary nucleotide DNA change and acts as a regulator of cell viability in the hematopoietic system.
Venturini L; Stadler M; Manukjan G; Scherr M; Schlegelberger B; Steinemann D; Ganser A
Exp Hematol; 2016 Apr; 44(4):257-68. PubMed ID: 26738774
[TBL] [Abstract][Full Text] [Related]
9. The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma.
Guan R; Hong W; Huang J; Peng T; Zhao Z; Lin Y; Yu M; Jian Z
J Gastrointest Oncol; 2020 Dec; 11(6):1305-1321. PubMed ID: 33457003
[TBL] [Abstract][Full Text] [Related]
10. Mining the prognostic significance and immune infiltration of
Zhou Y; Jiang S; Yu S; Zhu L; Liu Y; Li S; Hao N; Ren Y
Gland Surg; 2022 Apr; 11(4):720-741. PubMed ID: 35531108
[TBL] [Abstract][Full Text] [Related]
11. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
Zhai Q; Li H; Sun L; Yuan Y; Wang X
Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
[TBL] [Abstract][Full Text] [Related]
12. Expression and Prognostic Characteristics of m
Zhang B; Gu Y; Jiang G
Front Genet; 2020; 11():604597. PubMed ID: 33362863
[TBL] [Abstract][Full Text] [Related]
13. Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer.
Qi L; Zhou B; Chen J; Hu W; Bai R; Ye C; Weng X; Zheng S
J Cancer; 2019; 10(26):6618-6634. PubMed ID: 31777591
[No Abstract] [Full Text] [Related]
14. HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis.
Tan RSYC; Ong WS; Lee KH; Lim AH; Park S; Park YH; Lin CH; Lu YS; Ono M; Ueno T; Naito Y; Onishi T; Lim GH; Tan SM; Lee HB; Ryu HS; Han W; Tan VKM; Wong FY; Im SA; Tan PH; Chan JY; Yap YS
BMC Med; 2022 Mar; 20(1):105. PubMed ID: 35296300
[TBL] [Abstract][Full Text] [Related]
15. Low Expression of the Polycomb Protein RING1 Predicts Poor Prognosis in Human Breast Cancer.
Gao S; Wang SY; Zhang XD; Wu H; Pang D
Front Oncol; 2020; 10():618768. PubMed ID: 33634028
[TBL] [Abstract][Full Text] [Related]
16. The expression landscape of FOXP3 and its prognostic value in breast cancer.
Li J; Zhang X; Liu B; Shi C; Ma X; Ren S; Zhao X; Liu Y
Ann Transl Med; 2022 Jul; 10(14):801. PubMed ID: 35965804
[TBL] [Abstract][Full Text] [Related]
17. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates.
Fang Y; Liu J; Zhang Q; She C; Zheng R; Zhang R; Chen Z; Chen C; Wu J
World J Surg Oncol; 2022 Jun; 20(1):211. PubMed ID: 35729567
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
19. Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer.
Liu F; Wu H
J Inflamm Res; 2021; 14():97-114. PubMed ID: 33469338
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]